Michael P Pender Selected Research

Michael P Pender Research Topics

Disease

21	Multiple Sclerosis 04/2021 - 03/2004
4	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 11/2003
4	Epstein-Barr Virus Infections 10/2014 - 06/2009
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2008 - 09/2004
3	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 09/2004
3	Schizophrenia (Dementia Praecox) 04/2014 - 02/2005
3	Disease Progression 10/2012 - 09/2004
3	Inflammation (Inflammations) 10/2012 - 07/2004
2	Central Nervous System Diseases (CNS Diseases) 01/2017 - 11/2008
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2020
1	Fatigue 11/2018
1	Thyroid Diseases (Thyroid Disease) 01/2017
1	Vitamin D Deficiency 05/2013
1	Tertiary Lymphoid Structures 01/2012
1	Seasonal Allergic Rhinitis (Hay Fever) 05/2011
1	Hypersensitivity (Allergy) 05/2011
1	Asthma (Bronchial Asthma) 05/2011
1	Sunburn 11/2009
1	Nervous System Diseases (Neurological Disorders) 05/2008
1	Glioma (Gliomas) 06/2006
1	Glioblastoma (Glioblastoma Multiforme) 06/2006
1	Vascular Diseases (Vascular Disease) 04/2006
1	Neuroinflammatory Diseases 04/2006
1	Guillain-Barre Syndrome 05/2005
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 05/2005
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2005
1	Infections 11/2003
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2003
1	Chronic Progressive Multiple Sclerosis 01/2003

Drug/Important Bio-Agent (IBA)

6	AutoantibodiesIBA 10/2014 - 02/2005
5	Myelin Proteolipid ProteinIBA 01/2020 - 06/2004
4	AntigensIBA 10/2014 - 11/2003
4	Vitamin D FDA LinkGeneric 05/2013 - 05/2011
3	AntibodiesIBA 01/2020 - 09/2004
2	Proteins (Proteins, Gene)FDA Link 08/2020 - 05/2008
2	AutoantigensIBA 01/2017 - 11/2008
2	Antiviral Agents (Antivirals)IBA 10/2014 - 06/2009
2	RNA (Ribonucleic Acid)IBA 10/2014 - 12/2011
2	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 04/2014 - 02/2005
2	3' Untranslated Regions (3' UTR)IBA 05/2009 - 03/2009
2	Neurotransmitter Agents (Neurotransmitter)IBA 04/2006 - 02/2005
2	GangliosidesIBA 05/2005 - 01/2003
1	Immunoglobulin G (IgG)IBA 11/2018
1	Calcitonin Gene-Related PeptideIBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	Leucine (L-Leucine)FDA Link 01/2017
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2017
1	Crystallins (Crystallin)IBA 10/2014
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 04/2014
1	N 30IBA 04/2014
1	Interleukin-6 (Interleukin 6)IBA 10/2012
1	Cod Liver OilIBA 05/2011
1	Toll-Like Receptor 3IBA 05/2010
1	SiliconesIBA 11/2009
1	Leukemia Inhibitory FactorIBA 05/2009
1	Leukocyte Common Antigens (CD45 Antigen)IBA 02/2009
1	Myelin ProteinsIBA 05/2008
1	Estrogen ReceptorsIBA 01/2007
1	Glial Fibrillary Acidic ProteinIBA 06/2006
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2006
1	CatecholaminesIBA 04/2006
1	HomocysteineIBA 04/2006
1	TransferasesIBA 04/2006
1	EnzymesIBA 04/2006
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2006
1	catechol (pyrocatechol)IBA 04/2006
1	G(M1) GangliosideIBA 05/2005
1	Peptides (Polypeptides)IBA 03/2005
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2005
1	Chemokine ReceptorsIBA 09/2004
1	ChemokinesIBA 09/2004
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2004
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2004
1	CytokinesIBA 11/2003
1	G(M3) GangliosideIBA 01/2003

Therapy/Procedure

5	Immunotherapy 04/2021 - 06/2006
3	Therapeutics 01/2021 - 11/2018